Artwork

内容由Dr. Synaptologica提供。所有播客内容(包括剧集、图形和播客描述)均由 Dr. Synaptologica 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

55. Does the Introduction section have subheadings?

12:42
 
分享
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 30, 2025 15:07 (1M ago)

What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 490661098 series 3493940
内容由Dr. Synaptologica提供。所有播客内容(包括剧集、图形和播客描述)均由 Dr. Synaptologica 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Sub-sections and subheadings will be helpful.

The Methods and the Results sections of life-science papers are divided into sub-sections. And the sub-sections will have subheadings, i.e., the titles that serve as signposts of the sub-sections.

How about the Introduction section? What would this finding mean to us, the readers?

We will talk about them by scanning the Introduction of a paper written by Dr. Katalin Karikó & Dr. Drew Weissman, that led to the Nobel Prize in Physiology or Medicine 2023. We call it the Milestone Article 1. Here are two sets of links related to the paper.

Milestone Article 1:

- “Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA” by Karikó, Buckstein, Ni & Weissman. Immunity, 23(2): 165-75, 2005.

- HTML: https://doi.org/10.1016/j.immuni.2005.06.008

- PDF: https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf

- PubMed: https://pubmed.ncbi.nlm.nih.gov/16111635/

Copyright of the paper (as of March, 2025):

- See the pull-down menu “Article Info” near the top of the article webpage (Use the DOI above to reach it).

- Check the “User License” section which lists the “Elsevier user license”:

--- http://www.elsevier.com/open-access/userlicense/1.0/

--- https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user

This episode = mini-series: reading-35.

(My email is active. But my website is under construction. Please wait for a while. Thank you for the patience!)

  continue reading

61集单集

Artwork
icon分享
 

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on October 30, 2025 15:07 (1M ago)

What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Manage episode 490661098 series 3493940
内容由Dr. Synaptologica提供。所有播客内容(包括剧集、图形和播客描述)均由 Dr. Synaptologica 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Sub-sections and subheadings will be helpful.

The Methods and the Results sections of life-science papers are divided into sub-sections. And the sub-sections will have subheadings, i.e., the titles that serve as signposts of the sub-sections.

How about the Introduction section? What would this finding mean to us, the readers?

We will talk about them by scanning the Introduction of a paper written by Dr. Katalin Karikó & Dr. Drew Weissman, that led to the Nobel Prize in Physiology or Medicine 2023. We call it the Milestone Article 1. Here are two sets of links related to the paper.

Milestone Article 1:

- “Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA” by Karikó, Buckstein, Ni & Weissman. Immunity, 23(2): 165-75, 2005.

- HTML: https://doi.org/10.1016/j.immuni.2005.06.008

- PDF: https://www.cell.com/immunity/pdf/S1074-7613(05)00211-6.pdf

- PubMed: https://pubmed.ncbi.nlm.nih.gov/16111635/

Copyright of the paper (as of March, 2025):

- See the pull-down menu “Article Info” near the top of the article webpage (Use the DOI above to reach it).

- Check the “User License” section which lists the “Elsevier user license”:

--- http://www.elsevier.com/open-access/userlicense/1.0/

--- https://www.elsevier.com/about/policies-and-standards/open-access-licenses/elsevier-user

This episode = mini-series: reading-35.

(My email is active. But my website is under construction. Please wait for a while. Thank you for the patience!)

  continue reading

61集单集

すべてのエピソード

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

版权2025 | 隐私政策 | 服务条款 | | 版权
边探索边听这个节目
播放